Table 3: Stroke occurrence during NOACs.
DA: Dabigatran, RI: Rivaroxaban, AP: Apixaban, Type of stroke:- CE: Cardioembolic Stroke, AT: Atherothrombotic Brain Infarction, TIA: Transient Ischemic Attack, CH: Cerebral Hemorrhage
Case Age Initial dose of NOACs Prevention type Interval of recurrence Stroke type Possible reason of recurrence Secondary dose of NOACs BW (kg) Ccr (ml/min)
1 67 DA 300mg 2nd 510 CE Poor adherence DA 300mg 64 68
2 71 DA 220mg 2nd 85 AT Low dose DA 300mg 62 117
3 67 RI 15mg 1st 91 CE Post CABG DA 300mg 66 103
4 86 RI 10mg 2nd 385 CE RI 10mg 63 72
5 74 RI 10mg 1st 730 CE History of CH and stomach cancer DA 220mg 50 38
6 89 RI 10mg 2nd 160 AT AP 5mg 42 120
7 72 RI 15mg 2nd 160 CE AP 10mg 55 86
8 80 AP 5mg 1st 130 TIA AP 5mg 75 62
9 92 DA 220mg 2nd 50 CE High age AP 5mg 56 53
10 78 DA 220mg 2nd 300 CH Near the old lacune RI 10mg 52 78